| mTOR signaling disruption and its association with the development of autism spectrum disorder SD Thomas, NK Jha, S Ojha, B Sadek Molecules 28 (4), 1889, 2023 | 56 | 2023 |
| Pharmacological and molecular insight on the cardioprotective role of apigenin SD Thomas, NK Jha, SK Jha, B Sadek, S Ojha Nutrients 15 (2), 385, 2023 | 56 | 2023 |
| Repurposing dimethyl fumarate for cardiovascular diseases: pharmacological effects, molecular mechanisms, and therapeutic promise SD Thomas, NK Jha, B Sadek, S Ojha Pharmaceuticals 15 (5), 497, 2022 | 14 | 2022 |
| Targeting microglia in neuroinflammation: H3 receptor antagonists as a novel therapeutic approach for Alzheimer’s disease, Parkinson’s disease, and autism spectrum disorder SD Thomas, S Abdalla, N Eissa, A Akour, NK Jha, S Ojha, B Sadek Pharmaceuticals 17 (7), 831, 2024 | 8 | 2024 |
| Simultaneous antagonism at H3R/D2R/D3R reduces autism-like self-grooming and aggressive behaviors by mitigating MAPK activation in mice N Eissa, MA Awad, SD Thomas, K Venkatachalam, P Jayaprakash, ... International journal of molecular sciences 24 (1), 526, 2023 | 8 | 2023 |
| Alleviation of autophagic deficits and neuroinflammation by histamine H3 receptor antagonist E159 ameliorates autism-related behaviors in BTBR mice SD Thomas, P Jayaprakash, NZHJ Marwan, EABA Aziz, K Kuder, ... Pharmaceuticals 17 (10), 1293, 2024 | | 2024 |
| Targeting the CB (2) receptor to delay progression of cardiovascular diseases HM Hashiesh, NK Jha, SD Thomas, B Sadek, S Kumar, E Adeghate, ... Medicinal Usage of Cannabis and Cannabinoids, 171-182, 2023 | | 2023 |
